CDXS•globenewswire•
Codexis Announces Signing of Lease for GMP Manufacturing Facility
Summary
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it has signed a lease for a 34,000 square foot GMP manufacturing facility in Hayward, California.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 10, 2025 by globenewswire